Metagenomi Therapeutics, Inc. · Brief

Next report

10 days

Nov 11 · before openest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26—▼−1.63%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−1.63%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 11 report · est.

Bull2

41managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+2.88%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

10managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

8 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

MGX report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.